Epizyme (EPZM) Misses Q3 EPS by 16c

Epizyme (NASDAQ: EPZM) reported Q3 EPS of ($0.64), $0.16 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $5.2 million versus the consensus estimate of $13.18 million.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c